Cencora, Inc.
CORWholesale-Drugs, Proprietaries & Druggists' Sundries · SIC 5122 · CIK 0001140859
Revenue FY2025
$321.33B
Net Income
$1.55B
EPS (Basic)
$8.02
Net Margin
0.5%
ROE
103.1%
Total Equity
$1.51B
Shares Out
191M
Cencora, Inc. — Wholesale-Drugs, Proprietaries & Druggists' Sundries. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2007–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 6 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Fairview Capital Investment Management
Fairview Capital Investment Management
$2.2M
0.1%
—
Adage Capital Management
Adage Capital Management
$59.9M
0.1%
(33.6%)
Capital Research Global Investors
Capital Research Global Investors
$560.3M
0.1%
+1.0%
Suvretta Capital Management
Suvretta Capital Management
$3.5M
0.1%
—
Bridgewater Associates
Bridgewater Associates
$9.6M
0.0%
+139.3%
Alps Advisors
Alps Advisors
$0.6M
0.0%
NEW
Insider Transactions
Reading stored insider transactions…